CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 11, 2022 · earnings

NBIX earnings: a positive outcome, +7.4%

On February 11, 2022, Neurocrine Biosciences, Inc. reached its earnings. The result was a positive outcome, and the stock moved +7.4% in the window around the event.

The move

$79.60
1d before
$85.53
Event day
$85.53
1d after
$85.87
5d after

Pre-catalyst setup

+4.5%
30-day run-up
3994%
30-day volatility
1.2×
volume spike